The test is the first of several planned CLIA-waived assays from Cepheid, and the first point-of-care test on the market to differentiate flu from RSV.
The Enigma MiniLab runs single-tube multiplex panels at the point of care, with a lower price point than other commercially available syndromic panel platforms.
The assay runs on the company's fully automated PCR-based Idylla platform and detects various strains of the flu virus and respiratory syncytial virus.
A team of Chinese researchers has found using PCR and sequencing approaches that avian flu appears to have been transmitted between two unrelated people.
At AMP's annual meeting, a researcher presented results of a study to determine the Cobas Liat Influenza A/B assay's impact on clinical decision making in the ER.
The Malaysian company received CE-IVD marking for its PCR-based tests for influenza A/B and for cholera.
The firm has added 46 influenza strains and seven respiratory syncitial virus strains to its Simplexa Flu A/B & RSV Direct kit.
The test detects and differentiates influenza A and B in about 20 minutes. It is the second CLIA-waived test on Roche's Cobas Liat platform.
Researchers link a certain gene variant to increased risk of contracting severe flu, the Guardian reports.
St. Jude's Richard Webby will assess the performance of InDevR's FluChip-8G test on non-seasonal influenza viruses.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.